Navigation Links
Verenium Reports Financial Results for the First Quarter 2008
Date:5/5/2008

Specialty enzyme business delivers record growth; biofuels business advancing toward commercialization of next-generation cellulosic ethanol

CAMBRIDGE, Mass., May 5 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a pioneer in the development of next-generation cellulosic ethanol and high-performance specialty enzymes, today reported financial results for the first quarter of 2008 and provided updated 2008 financial guidance.

"I am encouraged by the overall results and achievements of the first quarter," said Carlos A. Riva, President and Chief Executive Officer of Verenium. "As planned, our demonstration-scale cellulosic ethanol facility -- the first of its kind in the nation -- entered the start-up phase and is proceeding on schedule despite significant cost escalation and labor shortages being experienced across the energy sector. At the same time, we achieved record quarterly product revenues and maintained healthy gross margins in our specialty enzyme business through our continued focus on achieving strong commercial results," Riva continued. "We will now build on these solid gains with a focus on prudently accelerating the development of both our business units."

Financial Results

Selected Financial Information

(unaudited, in thousands)

Three Months Ended

March 31,

2008 2007

Revenues:

Product:

Phyzyme(R) phytase $7,402 $3,778

All other products 3,799
'/>"/>

SOURCE Verenium Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Verenium Corporation to Present at Piper Jaffray Clean Technology & Renewables Conference
2. Verenium Explores Bacterial Genes Inside Termite Guts to Understand How Wood is Broken Down and Converted to Energy
3. Verenium Corporation to Present at the Pacific Growth Equities 2007 Clean Technology & Industrial Growth Conference
4. Verenium Advances Its Development Work With Cargill on a New Food-Related Product
5. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
6. ev3 Inc. Reports 2008 First Quarter Financial Results and Revised 2008 Guidance
7. United Therapeutics Reports First Quarter 2008 Financial Results
8. Endocare Reports 2008 First Quarter Financial Results
9. AMICAS Reports Financial Results for the First Quarter Ended March 31, 2008
10. LeMaitre Vascular Reports Q1 2008 Revenue of $11.8 Million, a 20% Increase
11. Anadys Pharmaceuticals Reports First Quarter 2008 Financial Results and Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... LONDON , May 29, 2015 ... forward as p ersonalized   treatments enter ... Despite generic erosion facing several of ... xinafoate), Symbicort (budesonide/formoterol fumarate) and Xolair (omalizumab), the global ... growth by the end of the decade.   ...
(Date:5/29/2015)... 29, 2015 Delcath Systems, Inc. (NASDAQ: ... device company focused on oncology with an emphasis ... cancers, announces that results of a large, European ... patients with hepatic metastases with the Delcath Hepatic ... an on-line abstract at the American Society of ...
(Date:5/29/2015)... May 29, 2015  Caris Life Sciences® today ... in which researchers utilized Caris Molecular Intelligence®, the ... potential therapeutic targets in patients with colorectal and ... programmed cell death protein 1 (PD-1) and its ... at the 2015 American Society of Clinical Oncology ...
(Date:5/29/2015)... DUBLIN , May 28, 2015 ... the addition of Jain PharmaBiotech,s new report ... their offering. This report deals with ... classical use mainly to describe the chromosome structure ... age of molecular biology, it is also referred ...
Breaking Biology Technology:Personalized Treatment for Severe Asthma to Drive Market Growth Despite Patent Expirations 2Personalized Treatment for Severe Asthma to Drive Market Growth Despite Patent Expirations 3Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 2Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 3Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 4Positive Data With Delcath's CHEMOSAT Highlighted At ASCO 2015 5Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 2Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 3Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 4Global Cytogenetics Market Report 2015-2024 - Technologies, Markets and Companies 2Global Cytogenetics Market Report 2015-2024 - Technologies, Markets and Companies 3
... China, Aug. 4 /Xinhua-PRNewswire-FirstCall/ --,Shengtai Pharmaceutical, Inc. ... Company"), a leading manufacturer and distributor,of high-quality, ... that it has retained Grayling Global to ... to shareholders, the investment,community and financial media., ...
... CryoLife, Inc. (NYSE: CRY ), a,biomaterials, medical device ... has been promoted to vice president of U.S. sales,and ... to vice,president of international sales and marketing. Both men ... worldwide sales and marketing.,Additionally, the company has announced the ...
... Radiometer today announced it,has received 510(k) clearance from ... FLEX CO-OX, a portable blood gas analyzer that ... expects commercial release,of the instrument to soon follow., ... The ABL80 FLEX CO-OX accurately measures pH, blood ...
Cached Biology Technology:Shengtai Pharmaceutical Retains Grayling Global As Investor Relations Counsel 2Shengtai Pharmaceutical Retains Grayling Global As Investor Relations Counsel 3CryoLife Announces Management Promotions 2CryoLife Announces Management Promotions 3New CO-oximetry Module for the ABL80 FLEX Blood Gas Analyzer 2
(Date:5/28/2015)... 28, 2015 Industry analyst firm n-tech ... report titled "Markets for Self-Healing Materials: 2015-2022." According to ... and vascular systems, biomaterials, relevant shape memory materials ... $2.7 billion by 2020. The report ... of smart materials. Other recent n-tech reports have included ...
(Date:5/22/2015)... According to a new market ... Thermal, Emotion, Forensic), by Software (Middleware, Databases), by Hardware (Cameras, ... and Home) - Global Forecast to 2020", published by ... in 2015 to $6.19 Billion by 2020, at a ... data Tables and   43 Figures spread through 140 ...
(Date:5/19/2015)... Fingerprint Cards (FPC) has received an ... and FPC1035 from one if its module partners. Deliveries are ... 2015 and the sensors will be used by smartphone manufacturers ... 2015 hereby amount to 740 MSEK to date. In addition ... and a number of smaller orders not separately communicated amounting ...
Breaking Biology News(10 mins):The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 2The Market for Self-Healing Materials to Reach $2.7 Billion by 2020 Says New n-tech Research Study 3Facial Recognition Market Worth $6.19 Billion by 2020 2Facial Recognition Market Worth $6.19 Billion by 2020 3Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2
... GAINESVILLE, Fla. New University of Florida research puts to ... the last glacial period. It turns out it ended up ... The findings have implications for modern-day global warming, said ... of the paper, which is published in this week,s journal ...
... team of researchers based at the Institute of Vertebrate ... professor at Washington University in St. Louis, has discovered ... anthropologists perceptions of the emergence of modern humans in ... published Oct. 25 in the online early edition of ...
... HOUSTON, Oct. 25, 2010 Some unexpected effects ... and reverse blindness have been uncovered by a University ... Donald A. Fox, a professor of vision sciences ... findings in a paper titled "Low-Level Gestational Lead Exposure ...
Cached Biology News:UF research gives clues about carbon dioxide patterns at end of Ice Age 2UF research gives clues about carbon dioxide patterns at end of Ice Age 3Unexpected findings of lead exposure may lead to treating blindness 2Unexpected findings of lead exposure may lead to treating blindness 3
... paraffin tissue array is designed for ... interest in extensive panels of different ... heart, kidney, liver, lung, muscle, spleen ... positively charged glass slide. Each ...
EPH electrode, anode, 1. Category: Electrophoresis Systems & Standards & Reagents, IEF & SDS-PAGE & 2-D Electrophoresis, Multiphor II Kits & Components and Accessories....
LIVE/DEAD® Sperm Viability Kit *200-1000 assays*...
in vitro Translation, Accessory Products...
Biology Products: